• Trial Status
  • Patients randomised:
  • 993

References

  1. Body SC, Mazer CD. Pro:Aprotinin Has a Good Efficacy and Safety Profile to other Alternatives for Prevention of Bleeding in Cardiac Surgery. Cardiovascular Anaesthesia 2006; 103:1354-1359.
  2. Beattie WS, Karkouti K. Con: Aprotinin Has a Good Efficacy and Safety Profile to other Alternatives for Prevention of Bleeding in Cardiac Surgery. Cardiovascular Anaesthesia 2006; 103:1359-1364.
  3. Mangano DT, the Multicenter Study of Perioperative Ischemia Research Group. Aspirin and Mortality from Coronary Bypass Surgery. N Engl J Med 2002; 347:1309-1317, Oct 24, 2002.
  4. United States Food and Drug Agency. Aprotinin Injection (marketed as Trasylol) [updated September 29, 2006].
  5. Harris G. FDA says Bayer failed to reveal drug risk study. (Published September 30 2006). New York Times
  6. Mangano D. T., Tudor I. C., Dietzel C., the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation. N Engl J Med 2006 Jan 26;354:353-65
  7. Sedrakyan A, Atkins D, Treasure T. The risk of aprotinin: a conflict of evidence. The Lancet 367; (9520):1376-1377
  8. Group. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71.
  9. Bélisle S, Hardy JF. Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg 1996;62:1908.
  10. Mangano D. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347:1309.
  11. The PEP Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295.
  12. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 1997;85:1258.
  13. Levi M, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940.
  14. Tunis S, et al. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:1624.